Newz Via
HomebusinessLiveMint-Business

Business News | Sun Pharma Q3FY26 Preview: Innovative portfolio, India market to drive growth

Author

By LiveMint-Business

Sun Pharma Q3FY26 Preview: Innovative portfolio, India market to drive growth
Representative Image • Source: LiveMint-Business
Analysts will also be seeking clarity on any potential impact from the US government’s most favoured nation pricing norms, and on the company’s plans after getting regulatory approval to market semaglutide as a weight-loss drug in India earlier this month.

More from Categories

Business

View All

Technology

View All

Sports

View All